Interferon gamma-1b: CNCT completed enrollment in its Phase III trial

Connetics Corp. (formerly Connective Therapeutics Inc., CNCT), Palo Alto, Calif. Product: Interferon gamma-1b Indication: Atopic dermatitis Status: CNCT completed enrollment in its Phase III double-b...